Cushing's Syndrome Due to Antiretroviral-Budesonide Interaction

被引：18

作者：

Frankel, Jonathan K. ^{[1
]}

Packer, Clifford D. ^{[1
,2
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Cleveland Hts, OH USA

[2] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA

来源：

ANNALS OF PHARMACOTHERAPY | 2011年 / 45卷 / 06期

关键词：

CYTOCHROME-P450; 3A; DRUG; RITONAVIR;

D O I：

10.1345/aph.1P731

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：823 / 824

页数：2

共 7 条

[1]

De Wachter Elke, 2003, J Cyst Fibros, V2, P72, DOI 10.1016/S1569-1993(03)00022-5

[2]

Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature [J].

Foisy, M. M. ;

Yakiwchuk, E. M. K. ;

Chiu, I. ;

Singh, A. E. .

HIV MEDICINE, 2008, 9 (06) :389-396

[3]

Proposal for a new tool to evaluate drug interaction cases [J].

Horn, John R. ;

Hansten, Philip D. ;

Chan, Lingtak-Neander .

ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) :674-680

[4]

Iatrogenic Cushing's Syndrome due to Coadministration of Ritonavir and Inhaled Budesonide in an Asthmatic Human Immunodeficiency Virus Infected Patient [J].

Kedem, Eynat ;

Shahar, Eduardo ;

Hassoun, Gamal ;

Pollack, Shimon .

JOURNAL OF ASTHMA, 2010, 47 (07) :830-831

[5]

A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[6]

Inhibition of cytochrome P450 3A:: Relevant drug interactions in gastroenterology [J].

Sagir, A ;

Schmitt, M ;

Dilger, K ;

Häussinger, D .

DIGESTION, 2003, 68 (01) :41-48

[7]

The gut as a barrier to drug absorption - Combined role of cytochrome P450 3A and P-glycoprotein [J].

Zhang, YC ;

Benet, LZ .

CLINICAL PHARMACOKINETICS, 2001, 40 (03) :159-168

← 1 →